Lithium in patients with amyotrophic lateral sclerosis (LiCALS): a phase 3 multicentre, randomised, double-blind, placebo-controlled trial

Controlled Trial ◽

Phase 3 ◽

Double Blind ◽

Double Blind Placebo ◽

Safety and efficacy of ceftriaxone for amyotrophic lateral sclerosis: a multi-stage, randomised, double-blind, placebo-controlled trial

The Lancet Neurology ◽

10.1016/s1474-4422(14)70222-4 ◽

2014 ◽

Vol 13 (11) ◽

pp. 1083-1091 ◽

Cited By ~ 124

Author(s):

Merit E Cudkowicz ◽

Sarah Titus ◽

Marianne Kearney ◽

Hong Yu ◽

Alexander Sherman ◽

...

Keyword(s):

Controlled Trial ◽

Double Blind ◽

Safety And Efficacy ◽

Double Blind Placebo ◽

Multi Stage ◽

Safety and efficacy of oral levosimendan in people with amyotrophic lateral sclerosis (the REFALS study): a randomised, double-blind, placebo-controlled phase 3 trial

The Lancet Neurology ◽

10.1016/s1474-4422(21)00242-8 ◽

2021 ◽

Vol 20 (10) ◽

pp. 821-831

Author(s):

Merit Cudkowicz ◽

Angela Genge ◽

Nicholas Maragakis ◽

Susanne Petri ◽

Leonard van den Berg ◽

...

Keyword(s):

Phase 3 ◽

Double Blind ◽

Safety And Efficacy ◽

Double Blind Placebo ◽

Safety and efficacy of edaravone in well defined patients with amyotrophic lateral sclerosis: a randomised, double-blind, placebo-controlled trial

The Lancet Neurology ◽

10.1016/s1474-4422(17)30115-1 ◽

2017 ◽

Vol 16 (7) ◽

pp. 505-512 ◽

Cited By ~ 289

Author(s):

Koji Abe ◽

Masashi Aoki ◽

Shoji Tsuji ◽

Yasuto Itoyama ◽

Gen Sobue ◽

...

Keyword(s):

Controlled Trial ◽

Double Blind ◽

Safety And Efficacy ◽

Double Blind Placebo ◽

A Randomized, Double Blind, Placebo-Controlled Trial of Pioglitazone in Combination with Riluzole in Amyotrophic Lateral Sclerosis

PLoS ONE ◽

10.1371/journal.pone.0037885 ◽

2012 ◽

Vol 7 (6) ◽

pp. e37885 ◽

Cited By ~ 84

Author(s):

Luc Dupuis ◽

Reinhard Dengler ◽

Michael T. Heneka ◽

Thomas Meyer ◽

Stephan Zierz ◽

...

Keyword(s):

Controlled Trial ◽

Double Blind ◽

Double Blind Placebo ◽

A double-blind, placebo-controlled trial of TRH in amyotrophic lateral sclerosis

Neurology ◽

10.1212/wnl.36.2.141 ◽

1986 ◽

Vol 36 (2) ◽

pp. 141-141 ◽

Cited By ~ 63

Author(s):

J. T. Caroscio ◽

J. A. Cohen ◽

J. Zawodniak ◽

V. Takai ◽

A. Shapiro ◽

...

Keyword(s):

Controlled Trial ◽

Double Blind ◽

Double Blind Placebo ◽

A double-blind placebo-controlled trial ofl-threonine in amyotrophic lateral sclerosis

Journal of Neurology ◽

10.1007/bf00862977 ◽

1992 ◽

Vol 239 (2) ◽

pp. 79-81 ◽

Cited By ~ 33

Author(s):

O. Blin ◽

J. Pouget ◽

G. Aubrespy ◽

C. Guelton ◽

A. Crevat ◽

...

Keyword(s):

Controlled Trial ◽

Double Blind ◽

Double Blind Placebo ◽

Safety and efficacy of lithium in combination with riluzole for treatment of amyotrophic lateral sclerosis: a randomised, double-blind, placebo-controlled trial

The Lancet Neurology ◽

10.1016/s1474-4422(10)70068-5 ◽

2010 ◽

Vol 9 (5) ◽

pp. 481-488 ◽

Cited By ~ 125

Author(s):

Swati P Aggarwal ◽

Lorne Zinman ◽

Elizabeth Simpson ◽

Jane McKinley ◽

Katherine E Jackson ◽

...

Keyword(s):

Controlled Trial ◽

Double Blind ◽

Safety And Efficacy ◽

Double Blind Placebo ◽

Selegiline Is Ineffective in a Collaborative Double-blind, Placebo-Controlled Trial for Treatment of Amyotrophic Lateral Sclerosis

Archives of Neurology ◽

10.1001/archneur.55.1.93 ◽

1998 ◽

Vol 55 (1) ◽

pp. 93 ◽

Cited By ~ 54

Author(s):

Dale J. Lange ◽

Peregrine L. Murphy ◽

Beverly Diamond ◽

Vicki Appel ◽

Eugene C. Lai ◽

...

Keyword(s):

Controlled Trial ◽

Double Blind ◽

Double Blind Placebo ◽

Double-Blind Placebo-Controlled Trial on the Use of Acetyl-L-Carnitine for the Treatment of Amyotrophic Lateral Sclerosis (P04.151)

Neurology ◽

10.1212/wnl.78.1_meetingabstracts.p04.151 ◽

2012 ◽

Vol 78 (Meeting Abstracts 1) ◽

pp. P04.151-P04.151

Author(s):

E. Beghi ◽

Italian ALS Study Group (*)

Keyword(s):

Controlled Trial ◽

Double Blind ◽

Double Blind Placebo ◽

A double-blind, placebo-controlled trial of high doses of gangliosides in amyotrophic lateral sclerosis

Neurology ◽

10.1212/wnl.39.12.1635 ◽

1989 ◽

Vol 39 (12) ◽

pp. 1635-1635 ◽

Cited By ~ 45

Author(s):

L. Lacomblez ◽

P. Bouche ◽

G. Bensimon ◽

V. Meininger

Keyword(s):

Controlled Trial ◽

Double Blind ◽

Double Blind Placebo ◽

High Doses ◽